Literature DB >> 31390082

Comparison between optical coherence tomographic and histopathologic appearances of artifacts caused by common surgical conditions and instrumentation.

Christina J Cocca1, Laura E Selmic1, Jonathan Samuelson2, Pin-Chieh Huang3,4, Jianfeng Wang3, Stephen A Boppart3,4,5,6.   

Abstract

OBJECTIVE: To document the appearance of artifacts created by commonly encountered surgical conditions and instrumentation on optical coherence tomography (OCT) and to compare these findings with histopathology. STUDY
DESIGN: Ex vivo study. ANIMALS: Five canine cadavers.
METHODS: Skin, subcutaneous fat, skeletal muscle, and fascia samples were obtained from fresh canine cadavers. Blood pooling, hemostatic crushing, scalpel blade cut, monopolar electrosurgery, bipolar vessel sealing device, and ultrasonic energy surgical artifacts were induced on each tissue type. Each specimen was imaged with OCT and subsequently histologically processed.
RESULTS: Most surgical instrumentation used for tumor excision created a high-scattering region with local architectural disruption. Blood pooling was visible as a high-scattering layer overlying tissue with normal architecture. Only the scalpel blade created a focal, low-scattering area representing a sharply demarcated cut within the tissue distinct from the appearance of other instrumentation.
CONCLUSION: Common surgical instruments and conditions encountered during tumor excision produced high-scattering OCT artifacts in tissues commonly seen at surgical margins. CLINICAL SIGNIFICANCE: The clinical value of OCT hinges on the ability of personnel to interpret this novel imaging and recognize artifacts. Defining and describing the appearance of common surgical artifacts provides a foundation to create image libraries with known histological and OCT interpretation, ultimately improving the diagnostic accuracy of OCT for assessment of surgical margins.
© 2019 The American College of Veterinary Surgeons.

Entities:  

Mesh:

Year:  2019        PMID: 31390082      PMCID: PMC7297464          DOI: 10.1111/vsu.13305

Source DB:  PubMed          Journal:  Vet Surg        ISSN: 0161-3499            Impact factor:   1.495


  14 in total

1.  Optical imaging technology in minimally invasive surgery. Current status and future directions.

Authors:  S A Boppart; T F Deutsch; D W Rattner
Journal:  Surg Endosc       Date:  1999-07       Impact factor: 4.584

Review 2.  Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy.

Authors:  J G Fujimoto; C Pitris; S A Boppart; M E Brezinski
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

3.  Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats.

Authors:  Valerie J Poirier; Douglas H Thamm; Ilene D Kurzman; K Ann Jeglum; Ruthanne Chun; Joyce E Obradovich; Maura O'Brien; Rogers M Fred; Brenda S Phillips; David M Vail
Journal:  J Vet Intern Med       Date:  2002 Nov-Dec       Impact factor: 3.333

4.  Optical coherence tomography.

Authors:  D Huang; E A Swanson; C P Lin; J S Schuman; W G Stinson; W Chang; M R Hee; T Flotte; K Gregory; C A Puliafito
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

5.  Intraoperative optical coherence tomography for soft tissue sarcoma differentiation and margin identification.

Authors:  Kelly J Mesa; Laura E Selmic; Paritosh Pande; Guillermo L Monroy; Jennifer Reagan; Jonathan Samuelson; Elizabeth Driskell; Joanne Li; Marina Marjanovic; Eric J Chaney; Stephen A Boppart
Journal:  Lasers Surg Med       Date:  2017-03-20       Impact factor: 4.025

6.  Intra-operative imaging of surgical margins of canine soft tissue sarcoma using optical coherence tomography.

Authors:  Laura E Selmic; Jonathan Samuelson; Jennifer K Reagan; Kelly J Mesa; Elizabeth Driskell; Joanne Li; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2018-11-13       Impact factor: 2.613

7.  Investigation of Optical Coherence Microelastography as a Method to Visualize Cancers in Human Breast Tissue.

Authors:  Brendan F Kennedy; Robert A McLaughlin; Kelsey M Kennedy; Lixin Chin; Philip Wijesinghe; Andrea Curatolo; Alan Tien; Maxine Ronald; Bruce Latham; Christobel M Saunders; David D Sampson
Journal:  Cancer Res       Date:  2015-06-29       Impact factor: 12.701

8.  Feline injection-site sarcoma: recurrence, tumour grading and surgical margin status evaluated using the three-dimensional histological technique.

Authors:  Chiara Giudice; Damiano Stefanello; Marcello Sala; Matteo Cantatore; Fulvia Russo; Stefano Romussi; Olga Travetti; Mauro Di Giancamillo; Valeria Grieco
Journal:  Vet J       Date:  2009-09-06       Impact factor: 2.688

9.  Intraoperative evaluation of breast tumor margins with optical coherence tomography.

Authors:  Freddy T Nguyen; Adam M Zysk; Eric J Chaney; Jan G Kotynek; Uretz J Oliphant; Frank J Bellafiore; Kendrith M Rowland; Patricia A Johnson; Stephen A Boppart
Journal:  Cancer Res       Date:  2009-11-15       Impact factor: 12.701

10.  Practical consensus recommendations for tumor margins and breast conservative surgery.

Authors:  R Sarin; S P Somsekhar; R Kumar; Gupta Pawan; Jain Sumeet; Jindal Pramoj; Zamre Vaishali; Pasha Firoz; P M Parikh; S Aggarwal; R Koul
Journal:  South Asian J Cancer       Date:  2018 Apr-Jun
View more
  2 in total

1.  Morpho-molecular signal correlation between optical coherence tomography and Raman spectroscopy for superior image interpretation and clinical diagnosis.

Authors:  Iwan W Schie; Fabian Placzek; Florian Knorr; Eliana Cordero; Lara M Wurster; Gregers G Hermann; Karin Mogensen; Thomas Hasselager; Wolfgang Drexler; Jürgen Popp; Rainer A Leitgeb
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

2.  Evaluating optical coherence tomography for surgical margin assessment of canine mammary tumours.

Authors:  Carolina Fabelo; Laura E Selmic; Pin-Cheh Huang; Jonathan P Samuelson; Jennifer K Reagan; Alexandra Kalamaras; Vincent Wavreille; Guillermo L Monroy; Marina Marjanovic; Stephen A Boppart
Journal:  Vet Comp Oncol       Date:  2020-07-26       Impact factor: 2.613

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.